A pharmacokinetics, pharmacodynamics, and safety study of evolocumab in healthy Chinese subjects
Latest Information Update: 04 Aug 2020
At a glance
- Drugs Evolocumab (Primary)
- Indications Coronary artery disease; Coronary disorders; Dyslipidaemias; Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemia type IIa; Myocardial infarction; Stroke
- Focus Pharmacokinetics
- 04 Aug 2020 New trial record
- 30 Jul 2020 Results published in the International Journal of Clinical Pharmacology and Therapeutics